A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis
Clinical trial NCT05070858 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05070858
- Sponsor
- Regeneron Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-14
- Primary completion
- 2025-07-08
- Enrollment
- 288
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.